Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GUNDSØ DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.5% 3.9% 5.0% 2.9% 2.8% 2.0% 12.8% 12.8%   Credit score (0-100)   65 51 44 56 59 67 18 18   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,926 2,010 2,073 1,480 1,811 2,166 0.0 0.0   EBITDA   329 230 169 390 392 653 0.0 0.0   EBIT   259 85.2 62.4 342 324 592 0.0 0.0   Pre-tax profit (PTP)   99.5 -43.7 -48.2 244.2 164.3 399.4 0.0 0.0   Net earnings   73.4 -35.5 -39.4 162.4 163.5 296.1 0.0 0.0   Pre-tax profit without non-rec. items   99.5 -43.7 -48.2 244 164 399 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,565 3,479 3,371 3,323 3,255 3,194 0.0 0.0   Shareholders equity total   824 789 749 939 1,103 1,399 1,274 1,274   Interest-bearing liabilities   2,978 2,495 2,247 2,130 1,804 1,500 0.0 0.0   Balance sheet total (assets)   5,072 5,391 5,214 5,112 4,727 4,544 1,274 1,274   Net Debt   2,945 2,470 2,202 2,106 1,764 1,397 -1,274 -1,274     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,926 2,010 2,073 1,480 1,811 2,166 0.0 0.0   Gross profit growth   -21.6% 4.4% 3.1% -28.6% 22.4% 19.6% -100.0% 0.0%   Employees   4 4 4 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% -50.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,072 5,391 5,214 5,112 4,727 4,544 1,274 1,274   Balance sheet change%   -2.8% 6.3% -3.3% -2.0% -7.5% -3.9% -72.0% 0.0%   Added value   329.0 229.9 169.5 389.9 372.4 653.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -100 -232 -214 -96 -136 -123 -3,194 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.5% 4.2% 3.0% 23.1% 17.9% 27.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.0% 1.6% 1.2% 6.6% 6.6% 12.8% 0.0% 0.0%   ROI %   6.3% 2.2% 1.8% 10.3% 9.8% 18.3% 0.0% 0.0%   ROE %   9.3% -4.4% -5.1% 19.2% 16.0% 23.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   16.2% 14.6% 14.4% 18.4% 23.3% 30.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   895.2% 1,074.3% 1,299.1% 540.2% 449.8% 213.7% 0.0% 0.0%   Gearing %   361.4% 316.4% 299.9% 226.8% 163.6% 107.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.2% 4.7% 4.7% 4.5% 8.1% 11.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.4 0.4 0.5 0.4 0.3 0.0 0.0   Current Ratio   0.9 0.8 0.7 0.7 0.6 0.7 0.0 0.0   Cash and cash equivalent   33.0 24.9 44.8 23.5 39.7 102.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -259.8 -550.3 -751.9 -735.5 -799.4 -670.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   82 57 42 195 186 218 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   82 57 42 195 196 218 0 0   EBIT / employee   65 21 16 171 162 197 0 0   Net earnings / employee   18 -9 -10 81 82 99 0 0